Stocks · News reference
Top 3 Risk Off Stocks That May Explode This Quarter
Opportunity to buy undervalued consumer staples stocks with RSI below 30: UVV, SFD, LWAY. UVV and SFD have 52-week lows, while SFD has record Q2 sales.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Lifeway Foods Q2 EPS $0.01, Sales $66.893M Beat $61.400M Estimate
Lifeway Foods (NASDAQ:LWAY) reported quarterly earnings of $0.01 per share. The company reported quarterly sales of $66.893 million which beat the analyst consensus estimate of $61.400 million by 8.95 percent. This is a
Full Transcript: Lifeway Foods Q2 2026 Earnings Call
Lifeway Foods (NASDAQ:LWAY) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs.
Top 3 Risk Off Stocks That Are Set To Fly This Month
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its
3 High-Yield Dividend Stocks Near Their 52-Week Lows That Income Investors Are Sleeping On
Three high-yield dividend stocks trading near 52-week lows—Crown Castle, Gaming & Leisure Properties, and Smithfield Foods—may be oversold despite recent bearish sentiment. Crown Castle's 5.6% yield could benefit from earnings recovery forecasts, Gaming & Leisure Properties' 7.5% yield is supported by escalating lease agreements, and Smithfield Foods' 5.6% yield appears sustainable given its 51% payout ratio and strategic pivot toward branded products.
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.